Tag: circulating tumor cells market forecast

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Circulating Tumor Cells Market?

The market size for circulating tumor cells has seen a swift expansion in recent times. It is predicted to rise from $11.9 billion in 2024 to approximately $13.37 billion in 2025, with a compound annual growth rate (CAGR) of 12.4%. The notable growth during the historic period can be associated with factors such as the rise in cancer cases, the usefulness of clinical staging in cancer treatments, the introduction of liquid biopsies, preference by patients for less invasive tests, regulatory backing for liquid biopsies, and a concentrated effort towards early cancer detection.

What Growth Rate Is Forecasted for the Circulating Tumor Cells Market by 2029?

Expectations predict a swift expansion in the circulating tumor cells market in the upcoming years. The market is projected to escalate to $21.68 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.8%. The considerable growth in the forecast period is linked to point-of-care CTC testing, the use of microfluidics, emphasis on rare cancer types, standardization of CTC assays, increase in CTC-based clinical trials, and economic growth in emergent markets. Key trends during this period consist of innovative approaches in CTC isolation, government-sponsored funding for CTC research, progress in CTC detection technologies, the application of liquid biopsy for cancer surveillance, integration with single-cell analysis, and the merging of technology with artificial intelligence (AI).

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Which Key Companies Are Shaping the Future of the Circulating Tumor Cells Market?

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

Which Factors Are Driving Demand in the Circulating Tumor Cells Industry?

The escalating prevalence of cancer is anticipated to fuel the expansion of the circulating tumor cells market. Cancer is a condition where certain cells in the body grow without control, spreading to other areas. Circulating tumor cells play a crucial role in early cancer detection and diagnosis; thus, their demand increases with the rising prevalence of cancer. To illustrate, the American Cancer Society Journals, a humanitarian health organization from the US, predicted in January 2023 that around 1,958,310 new instances of cancer would be identified, potentially leading to 609,820 deaths related to cancer in the United States. Hence, the increasing prevalence of cancer is a significant propelling factor for the circulating tumor cells market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

How Is the Circulating Tumor Cells Market Segmented by Several Divisions?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

What are the Emerging Market Trends Driving the Growth of the Circulating Tumor Cells Industry?

Innovative product development is emerging as a main trend in the circulating tumor cells industry. Significant players in this market are investing in the creation of groundbreaking products to cement their market standing. For illustration, Bio-Rad Laboratories, Inc., a medical laboratory based in the United States, kickstarted this trend in June 2024 by launching Celselect Slides 2.0. This product is engineered to optimize the capture of uncommon cells and circulating tumor cells (CTCs), thus boosting precision and productivity in cell analysis for clinical and research purposes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Regions Are Driving Growth in the Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

This Report Delivers Insight On:

1. How big is the circulating tumor cells market, and how is it changing globally?

2. Who are the major companies in the circulating tumor cells market, and how are they performing?

3. What are the key opportunities and risks in the circulating tumor cells market right now?

4. Which products or customer segments are growing the most in the circulating tumor cells market?

5. What factors are helping or slowing down the growth of the circulating tumor cells market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Circulating Tumor Cells Market?

The market size for circulating tumor cells has seen a swift expansion in recent times. It is predicted to rise from $11.9 billion in 2024 to approximately $13.37 billion in 2025, with a compound annual growth rate (CAGR) of 12.4%. The notable growth during the historic period can be associated with factors such as the rise in cancer cases, the usefulness of clinical staging in cancer treatments, the introduction of liquid biopsies, preference by patients for less invasive tests, regulatory backing for liquid biopsies, and a concentrated effort towards early cancer detection.

What Growth Rate Is Forecasted for the Circulating Tumor Cells Market by 2029?

Expectations predict a swift expansion in the circulating tumor cells market in the upcoming years. The market is projected to escalate to $21.68 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.8%. The considerable growth in the forecast period is linked to point-of-care CTC testing, the use of microfluidics, emphasis on rare cancer types, standardization of CTC assays, increase in CTC-based clinical trials, and economic growth in emergent markets. Key trends during this period consist of innovative approaches in CTC isolation, government-sponsored funding for CTC research, progress in CTC detection technologies, the application of liquid biopsy for cancer surveillance, integration with single-cell analysis, and the merging of technology with artificial intelligence (AI).

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Which Key Companies Are Shaping the Future of the Circulating Tumor Cells Market?

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

Which Factors Are Driving Demand in the Circulating Tumor Cells Industry?

The escalating prevalence of cancer is anticipated to fuel the expansion of the circulating tumor cells market. Cancer is a condition where certain cells in the body grow without control, spreading to other areas. Circulating tumor cells play a crucial role in early cancer detection and diagnosis; thus, their demand increases with the rising prevalence of cancer. To illustrate, the American Cancer Society Journals, a humanitarian health organization from the US, predicted in January 2023 that around 1,958,310 new instances of cancer would be identified, potentially leading to 609,820 deaths related to cancer in the United States. Hence, the increasing prevalence of cancer is a significant propelling factor for the circulating tumor cells market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

How Is the Circulating Tumor Cells Market Segmented by Several Divisions?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

What are the Emerging Market Trends Driving the Growth of the Circulating Tumor Cells Industry?

Innovative product development is emerging as a main trend in the circulating tumor cells industry. Significant players in this market are investing in the creation of groundbreaking products to cement their market standing. For illustration, Bio-Rad Laboratories, Inc., a medical laboratory based in the United States, kickstarted this trend in June 2024 by launching Celselect Slides 2.0. This product is engineered to optimize the capture of uncommon cells and circulating tumor cells (CTCs), thus boosting precision and productivity in cell analysis for clinical and research purposes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Regions Are Driving Growth in the Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

This Report Delivers Insight On:

1. How big is the circulating tumor cells market, and how is it changing globally?

2. Who are the major companies in the circulating tumor cells market, and how are they performing?

3. What are the key opportunities and risks in the circulating tumor cells market right now?

4. Which products or customer segments are growing the most in the circulating tumor cells market?

5. What factors are helping or slowing down the growth of the circulating tumor cells market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the circulating tumor cells industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Key Projections for the CAGR of the Circulating Tumor Cells Market Size From 2025 to 2034?

In recent times, we’ve seen a speedy expansion in the circulating tumor cells market size. The market, that was valued at $11.9 billion in 2024, is expected to surge to $13.37 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.4%. The prompt growth witnessed during the historic period can be linked to various factors such as the increasing occurrence of cancer, its rising prevalence, utility in cancer staging, the emergence of liquid biopsy, the incline of patients towards minimally invasive tests, strong regulatory support for liquid biopsies, and an increased emphasis on early detection of cancer.

The market size of circulating tumor cells is predicted to experience swift expansion in the coming years, escalating to $21.68 billion in 2029 with a compound annual growth rate (CAGR) of 12.8%. The predicted increase during the forecast period is due to factors such as point-of-care CTC examinations, incorporation of microfluidics, concentration on unusual cancer varieties, standardization of CTC tests, growth of clinical trials based on CTC, and economic growth in emerging markets. Noteworthy trends during the forecast period include advancements in techniques for isolating CTC, government financial support for CTC research, advancements in the technology used for detecting CTC, liquid biopsy for monitoring cancer, integration with individual cell analysis, and technological merger with artificial intelligence (AI).

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Are the Core Growth Drivers Propelling the Circulating Tumor Cells Market Forward?

The anticipated growth of the circulating tumor cells market is linked to the rising prevalence of cancer. Cancer is described as a condition where some bodily cells proliferate uncontrollably and disseminate to other sections. Circulating tumor cells aid in the early identification and diagnosis of this disease, making the escalation of cancer a contributing factor to the market’s expansion. For example, the American Cancer Society Journals, a volunteer health organization based in the U.S., forecasted in January 2023 that there would be 1,958,310 new instances of cancer diagnosed and 609,820 cancer-related fatalities in the U.S. Hence, the increasing cancer incidence is propelling the circulating tumor cells market’s growth.

What Segment Types Define the Circulating Tumor Cells Market Structure?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Emerging Trends that Are Influencing theCirculating Tumor Cells Industry Evolution?

One significant trend emerging in the circulating tumor cells market is the emphasis on product innovation. Major industry players are concentrating on the development of unique products to cement their market position. For example, in June 2024, Bio-Rad Laboratories, Inc., a medical lab based in the U.S., released Celselect Slides 2.0. This product is built to improve the collection of rare cells and circulating tumor cells (CTCs), thereby boosting the precision and effectiveness of cell analysis in clinical and research settings.

View the full report here:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

What Is the Definition of the Circulating Tumor Cells Market?

Circulating tumor cells refer to solid tumor-derived cells that have shed from the primary tumor and are extravasated into the blood circulation system. They are used as a tool to diagnose and prognosis of cancer.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theCirculating Tumor Cells Market from 2025 to 2034?

The escalating prevalence of cancer is anticipated to spur the advancement of the circulating tumor cells market. Cancer is characterized as a condition where some cells in the body multiply chaotically and spread to different areas. Circulating tumor cells play a pivotal role in the early discovery and diagnosis of cancer, hence the escalating prevalence of it fosters the expansion of the circulating tumor cells market. To illustrate, the American Cancer Society Journals, a voluntary health organization based in the US, predicted in January 2023 that there would be 1,958,310 newly diagnosed cancer cases, anticipating 609,820 cancer-related deaths in the United States. Consequently, the escalating cancer prevalence fuels the growth of the circulating tumor cells market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

#What is the Anticipated CAGR of theCirculating Tumor Cells Market, and What Factors Will Drive It?

Over the past few years, there has been significant growth in the market size of circulating tumor cells. The market, which stood at $11.9 billion in 2024, is projected to expand to $13.37 billion in 2025, showing a compound annual growth rate (CAGR) of 12.4%. The surge in growth during the historic period can be connected to the incidence and prevalence of cancer, the usefulness of these cells in cancer staging, the advent of liquid biopsies, the patient’s preference for less invasive tests, regulatory backing for liquid biopsies, and a concentrated effort towards early detection of cancer.

Expectations are high for the circulating tumor cells market to experience substantial growth in the coming years, with projections reaching $21.68 billion by 2029 at a compound annual growth rate (CAGR) of 12.8%. This anticipated growth during the forecast period can be credited to the implementation of point-of-care CTC testing, the acceptance of microfluidics, a heightened focus on uncommon types of cancer, the standardization of CTC assays, the increasing number of CTC-based clinical trials, as well as economic and emerging market expansion. Prominent trends set to arise during the forecast period encompass advancements in CTC isolation methods, an increase in government funding towards CTC research, development in CTC detection technology, the growing use of liquid biopsy for monitoring cancer, the integration with single-cell analysis, and the technological merging with artificial intelligence (AI).

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

How Are Market Trends and Innovations Revolutionizing theCirculating Tumor Cells Industry in Recent Times?

Trend 1:

The proliferating trend of product innovations is making waves in the circulating tumor cells market. Many leading corporations in this market are intently focused on unveiling cutting-edge products to solidify their market standing. An example of this would be Bio-Rad Laboratories, Inc., an American medical laboratory, who in June 2024 launched the Celselect Slides 2.0. This product is meticulously crafted to intensify the rare and circulating tumor cells (CTCs) capture, thereby enhancing the precision and productivity of cell analysis for both clinical and academic applications.

Which Key Market Players Are Shaping the Future and Growth of theCirculating Tumor Cells Market?

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

What Are the Core Segments of the Circulating Tumor Cells Market, and How Do They Contribute to Growth?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smpGlobal Circulating Tumor Cells Market, Global Circulating Tumor Cells Market Report, Global Circulating Tumor Cells Market Trends, Global Circulating Tumor Cells Market Size

Browse Through More Reports Similar to the Gobal Circulating Tumor Cells Maret 2025, By The Business Research Company:

Cardiovascular Surgery Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Electrosurgical Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electrosurgical-devices-and-equipment-global-market-report

Robotic Surgery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/robotic-surgery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the circulating tumor cells market grown over the years?

In recent times, the market size for circulating tumor cells has seen phenomenal growth. Projected growth from $11.9 billion in 2024 to $13.37 billion in 2025, with a compound annual growth rate (CAGR) of 12.4%, indicates a booming market. The historic growth has been driven by factors such as the prevalence and incidence of cancer, the usefulness of these cells in cancer staging, the introduction of liquid biopsy, patient preference for less invasive tests, regulatory backing for liquid biopsies, and an emphasis on early detection of cancer.

What Is the forecasted market size and growth rate for the circulating tumor cells market?

The market size of circulating tumor cells is predicted to undergo swift expansion in the forthcoming years, with estimates suggesting a growth to $21.68 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The anticipated growth during the forecast period can be linked to factors such as the uptake of point-of-care CTC testing, the use of microfluidics, attention to unique cancer forms, standardization of CTC tests, development of CTC-centric clinical trials, as well as financial growth and expansion in emerging markets. Key trends for the forecast period feature developments in CTC extraction methods, state funding for CTC research, improvements in CTC detection technology, the utilization of liquid biopsy for cancer surveillance, integration with single-cell analysis, and technological fusion with artificial intelligence (AI).

Get your circulating tumor cells market report here!

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

What are the major factors driving growth in the circulating tumor cells market?

The escalating prevalence of cancer is anticipated to fuel the expansion of the circulating tumor cells market. Cancer is characterized by the uncontrolled proliferation of a few cells within the body, which metastasize to different parts. Circulating tumor cells aid in early cancer detection and diagnosis, thereby, their demand increases parallelly with the surge in cancer incidence. For example, the American Cancer Society Journals, an American voluntary health entity, estimated in January 2023 that the US would have 1,958,310 new cancer diagnoses and about 609,820 cancer-related deaths. Consequently, the escalating prevalence of cancer is propelling the expansion of the circulating tumor cells market.

What key areas define the segmentation of the global circulating tumor cells Market?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What are the top market players propelling the growth of the circulating tumor cells industry?

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

What are the key trends shaping the future of the circulating tumor cells market?

One of the prominent trends making waves in the circulating tumor cells market is product innovation. Leading companies in this market are intent on creating novel products to solidify their market standing. A case in point is Bio-Rad Laboratories, Inc., a medical laboratory based in the US, which rolled out the Celselect Slides 2.0 in June 2024. This product has been developed to boost the capture of scarce cells and circulating tumor cells (CTCs), thereby enhancing the precision and productivity of cell analysis for clinical and research purposes.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

What regions are dominating the circulating tumor cells market growth?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Surgery Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Electrosurgical Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electrosurgical-devices-and-equipment-global-market-report

Robotic Surgery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/robotic-surgery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Future CAGR of the Circulating Tumor Cells Market, and How Will It Impact Industry Expansion?

Over the recent years, the market size of circulating tumor cells has seen a quick expansion. It’s predicted to increase from $11.9 billion in 2024 to $13.37 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.4%. Factors contributing to the growth during the historic period include the occurrence and prevalence of cancer, the use of these cells in cancer staging, the development of liquid biopsy, patient preference for minimally invasive examinations, regulatory backing for liquid biopsies, and an emphasis on the early detection of cancer.

The market size for circulating tumor cells is projected to witness a significant upsurge in the forthcoming years, expanding to a staggering $21.68 billion in 2029 with a compound annual growth rate (CAGR) of 12.8%. The anticipated growth over the forecast timeline can be credited to factors such as the adoption of point-of-care CTC testing, the embracement of microfluidics, focus on rare types of cancer, standardization of CTC assays, enhanced CTC-based clinical trials, as well as economic and emerging market development. Key trends to watch out for during the forecast timeframe include novel techniques for CTC isolation, governmental funding for studies on CTC, strides in CTC detection technologies, use of liquid biopsy for monitoring cancer, merging with single-cell analysis, and the harmonization with artificial intelligence (AI) technology.

What Are the Primary Drivers Supporting the Growth of the circulating tumor cells Market?

The escalating occurrence of cancer is anticipated to boost the growth of the circulating tumor cells market. Cancer is a disease known for uncontrollable growth and spread of some body cells. The use of circulating tumor cells is vital in the preliminary detection and diagnosis of cancer, hence, the increasing incidence of cancer is triggering the expansion of this market. For instance, the American Cancer Society Journals, an organization based in the US, forecasted in January 2023 that there would be approximately 1,958,310 newly diagnosed cancer cases, alongside an expected 609,820 cancer-related fatalities in the United States. As such, the rising incidence of cancer continues to fuel the development of the circulating tumor cells market.

Explore Comprehensive Insights Into The Global Circulating Tumor Cells Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Are the Top Market Players Propelling the Growth of the Circulating Tumor Cells Industry?

Major companies operating in the circulating tumor cells market include:

• Precision Medicine Group LLC_x000D_

• Bio-Techne Corporation_x000D_

• BIOCEPT Inc._x000D_

• Creativ MicroTech Inc._x000D_

• Fluxion Biosciences Inc._x000D_

What Are the Key Trends to Watch in the Circulating Tumor Cells Market Over the Coming Years?

One of the prevalent trends in the circulating tumor cells market is product innovation. Many of the leading businesses in the industry are focusing on creating novel products to consolidate their market position. As an example, Bio-Rad Laboratories, Inc., a medical laboratory based in the US, introduced the Celselect Slides 2.0 in June 2024. This product is intended to improve the capture of scarce cells and circulating tumor cells (CTCs), thereby increasing the precision and effectiveness of cell analysis for both clinical and research uses.

Secure Your Global Circulating Tumor Cells Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Circulating Tumor Cells Market?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

What Regions Are Dominating the Circulating Tumor Cells Market Growth?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Do Experts Define the Scope of the Circulating Tumor Cells Market?

Circulating tumor cells refer to solid tumor-derived cells that have shed from the primary tumor and are extravasated into the blood circulation system. They are used as a tool to diagnose and prognosis of cancer.

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Surgery Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Electrosurgical Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electrosurgical-devices-and-equipment-global-market-report

Robotic Surgery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/robotic-surgery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: